title: [Polymyalgia rheumatica in daily routine practice].
abstract: Polymyalgia rheumatica (PMR) is a very painful inflammatory disease which regularly affects the shoulder region but in 70% of cases the pelvic girdle region is also affected. The disease occurs in people over the age of 50 years and reaches a peak at 72 years old. Women are affected twice as often as men. The prevalence is estimated to be 0.3-0.7% in the Caucasian population over 50 years old.
  Misdiagnosis of PMR is common. The differential diagnosis primarily includes impingement syndrome, osteoarthritis of the shoulders, calcifying tendinitis of the rotator cuff, bursitis, omarthritis or inflammatory rheumatic diseases, such as rheumatoid arthritis. Taking a structured medical history and performing a thorough clinical examination are crucial. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are usually highly elevated and should be investigated particularly in patients who present with new onset bilateral shoulder pain and pronounced general impairment of movement. Imaging shows characteristic inflammatory changes around the shoulders and hip joints. The new European League Against Rheumatism and American College of Rheumatology (EULAR/ACR) classification criteria of PMR including ultrasound imaging are superior to previous classification and diagnostic criteria in terms of positive and negative predictive values.
  
  
  METHODS
  Glucocorticoids are still the mainstay of treatment. Recommended daily prednisolone starting doses are between 15 mg and 25 mg with a weekly dose reduction until 10 mg/day and then further dose reductions of 1 mg per month. Methotrexate can aid reducing prednisolone doses in patients who fail to reach doses below the Cushing threshold quickly enough, which can have major side effects.
authors.affiliation: Orthopädie, Rheumatologie, Traumatologie, Praxis "Orthos", AnsbacherStr. 17-19, 10780, Berlin, Deutschland, martingelore@t-online.de.
authors.forename: M
authors.initials: M
authors.lastname: Talke
authors.forename: W A
authors.initials: WA
authors.lastname: Schmidt
mesh_terms: D017677:Age Distribution; D000368:Aged; D003937:Diagnosis, Differential; D003955:Diagnostic Tests, Routine / Q000379:methods; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008487:Medical History Taking; D008875:Middle Aged; D010147:Pain Measurement / Q000379:methods; D010808:Physical Examination; D011111:Polymyalgia Rheumatica / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D010818:Practice Patterns, Physicians'; D015995:Prevalence; D017678:Sex Distribution; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents